Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.32 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 2/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CCL2 | P13500 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29386338 | 1.00 | HTR2A (0.40) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| SCHEMBL30373042 | 0.98 | HTR2A (0.41) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Butadiene SCHEMBL8668560 | 0.81 | HTR6 (0.32) | HTR2AHTR6SIGMAR1 | |
| SCHEMBL8664613 | 0.80 | NOTUM (0.32) | HTR2AHTR6 | |
| SCHEMBL8671280 | 0.80 | HTR6 (0.31) | HTR2AHTR6 | |
| SCHEMBL8665644 | 0.77 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL8666257 | 0.77 | MAOB (0.44) | SIGMAR1KDM4ECYP2D6LMNACYP3A4 | |
| Hydrochloric Acid SCHEMBL8040766 | 0.74 | MAOA (0.35) | KDM4ELMNACYP3A4HSD17B10MEN1 | |
| SCHEMBL5698322 | 0.72 | HTR2A (0.44) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL550006 | 0.71 | HTR2A (0.40) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11597839-B2 | Methods for making an object and formulations for use in said methods | PHOTOCENTRIC LIMITED (GB) | 2023-03-07 | — | — | US | claimed |
| EP-3541856-A1 | METHODS FOR MAKING A METAL, SAND OR CERAMIC OBJECT BY ADDITIVE MANUFACTURE AND FORMULATIONS FOR USE IN SAID METHODS | Photocentric Limited (GB) | 2019-09-25 | — | — | EP | claimed |
| US-20180299779-A1 | METHOD FOR MAKING A LITHOGRAPHIC PRINTING PLATE | PHOTOCENTRIC LIMITED (GB) | 2018-10-18 | — | — | US | claimed |
| US-20180282544-A1 | Methods For Making An Object And Formulations For Use In Said Methods | PHOTOCENTRIC LIMITED (GB) | 2018-10-04 | — | — | US | claimed |
| EP-3353604-A1 | METHODS FOR MAKING AN OBJECT AND FORMULATIONS FOR USE IN SAID METHODS | Photocentric Limited (GB) | 2018-08-01 | — | — | EP | claimed |
| WO-2018091891-A1 | METHODS FOR MAKING A METAL, SAND OR CERAMIC OBJECT BY ADDITIVE MANUFACTURE AND FORMULATIONS FOR USE IN SAID METHODS | PHOTOCENTRIC LIMITED (GB) | 2018-05-24 | — | — | WO | claimed |
| EP-2107423-B1 | Titanocene containing photoconductors | XEROX CORP (US) | 2013-05-29 | — | — | EP | claimed |
| US-8088542-B2 | Overcoat containing titanocene photoconductors | XEROX CORPORATION (US) | 2012-01-03 | — | — | US | claimed |
| US-7811732-B2 | Titanocene containing photoconductors | XEROX CORPORATION (US) | 2010-10-12 | — | — | US | claimed |
| EP-2107423-A1 | Titanocene containing photoconductors | Xerox Corporation (US) | 2009-10-07 | — | — | EP | claimed |
| US-20090246663-A1 | TITANOCENE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-10-01 | — | — | US | claimed |
| US-20090246657-A1 | OVERCOAT CONTAINING TITANOCENE PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-10-01 | — | — | US | claimed |
| US-20250129487-A1 | PRODUCTION METHOD FOR AMMONIA AND PRODUCTION DEVICE | NISSAN CHEMICAL CORPORATION (JP) | 2025-04-24 | — | — | US | disclosed |
| US-20230295813-A1 | AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11597839-B2 | Methods for making an object and formulations for use in said methods | PHOTOCENTRIC LIMITED (GB) | 2023-03-07 | — | — | US | disclosed |
| US-20220324895-A1 | DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER | UNIV NEW YORK (US) | 2022-10-13 | — | — | US | disclosed |
| EP-0796875-A2 | Process for the preparation of crystalline vinylaromatic polymers with a predominant syndiotactic structure | ENICHEM S.p.A. (IT) | 1997-09-24 | — | — | EP | disclosed |
| EP-0780405-A1 | Process for the preparation of crystalline vinylaromatic polymers with a predominantly syndiotactic structure | ENICHEM S.p.A. (IT) | 1997-06-25 | — | — | EP | disclosed |
| EP-0768320-A1 | Catalyst component and catalyst | NIPPON OIL CO. LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
| EP-0768319-A1 | Process for the production of polyolefins | NIPPON OIL CO. LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324895-A1 | DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER | ALG1, PPOX, MANBA | CHRM2 2163/4885CHRM1 1997/4885CHRM3 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.